TrialAdvances in therapy2025

Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial.

Ingmar Bergs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.